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Background: Alcoholic beverages are widely consumed. Depression, the most prevalent mental disorder
worldwide, has been related to alcohol intake. We aimed to prospectively assess the association between alcohol
intake and incident depression using repeated measurements of alcohol intake.
Methods: We followed-up 5,505 high-risk men and women (55 to 80 y) of the PREDIMED Trial for up to seven
years. Participants were initially free of depression or a history of depression, and did not have any history of
alcohol-related problems. A 137-item validated food frequency questionnaire administered by a dietician was
repeated annually to assess alcohol intake. Participants were classified as incident cases of depression when they
reported a new clinical diagnosis of depression, and/or initiated the use of antidepressant drugs. Cox regression
analyses were fitted over 23,655 person-years.
Results: Moderate alcohol intake within the range of 5 to 15 g/day was significantly associated with lower risk of
incident depression (hazard ratio (HR) and 95% confidence interval (95% CI) = 0.72 (0.53 to 0.98) versus abstainers).
Specifically, wine consumption in the range of two to seven drinks/week was significantly associated with lower
rates of depression (HR (95% CI) = 0.68 (0.47 to 0.98)).
Conclusions: Moderate consumption of wine may reduce the incidence of depression, while heavy drinkers seem
to be at higher risk.
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Most cultures and countries include alcoholic beverages
as part of their usual diet. Alcohol intake is different
over world regions regarding the habitual type of beverage
and the pattern of consumption (frequency and average
intake). In general terms, the consumption of alcoholic
beverages is increasing worldwide [1]. Unipolar depression
is the most prevalent mental disorder in the world and it
is increasing steadily [2].
The simultaneous presence of alcohol-related problems
and depression is common [3]. However, problematic* Correspondence: mamartinez@unav.es
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reproduction in any medium, provided the orintake needs to be distinguished from moderate intake.
Problematic alcohol intake may be associated with depres-
sion not only because of increased intake of ethanol but
also because of other alcohol-related unhealthy lifestyles or
because of the social environment surrounding problematic
drinkers (job loss, family problems, financial problems or
other addictions). Any of these circumstances may be a
potential trigger for depression, even in the absence of a
specific detrimental role for ethanol.
Unipolar depression and cardiovascular disease are likely
to share some common pathophysiological mechanisms.
Moderate alcohol intake, especially alcohol from wine, has
been repeatedly reported to be inversely associated with
the incidence of cardiovascular disease [4-6]. Some of the
responsible mechanisms for this inverse association are
likely to be involved also in a reduced risk of depression. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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alcohol use and depression, longitudinal studies are incon-
sistent [9-20]. However, none of them has investigated the
specific role of each beverage. Neither have they used
repeated measurements on alcohol intake during follow-up
to update the information on exposure to alcohol.
We prospectively evaluated the incidence of depression
among light to moderate drinkers from an older Mediter-
ranean cohort at high cardiovascular risk using repeated
measurements of intake. An interesting characteristic
of this population is that wine was the most frequently
consumed alcoholic beverage. We also evaluated specific-
ally the association of wine with incident depression, using
repeated measurements of wine consumption.Methods
Subjects
We assessed participants from the PREDIMED Study
(“Prevención con Dieta Mediterránea” (Prevention with
Mediterranean Diet)), which is a large, parallel-group,
randomized, multicenter, controlled, clinical trial conducted
in Spain. The aim of the PREDIMED trial was to assess
the effect of the Mediterranean diet on the primary
prevention of cardiovascular disease (www.predimed.es;
www.predimed.org) [21].
Participants were men and women aged 55 to 80 and 60
to 80 years, respectively. They were free of cardiovascular
disease at baseline and met at least one of the two following
criteria: type 2 diabetes mellitus or the presence of three
or more coronary heart disease risk factors.
Previous history of cardiovascular disease, any severe
chronic illness, history of food allergy, intolerance to
olive oil or nuts, drug addiction or chronic alcoholism
were exclusion criteria in the PREDIMED trial. Subjects
were screened for problematic use of alcohol using the
CAGE questionnaire (a four-item screening tool) [21] and
they were not included in the trial if they answered
positively to at least two questions on this questionnaire.
Participants who met the previous inclusion criteria
(n = 7,447) were randomly assigned to three interventions:
Mediterranean diet supplemented with extra virgin olive
oil, Mediterranean diet supplemented with mixed nuts or
a control group. They were annually interviewed by a
dietician, obtaining information about lifestyle, diet and
incident diseases. Further aspects of the methods and
design of the PREDIMED trial have been reported else-
where in detail [22,23]. The Research and Ethic Committee
of the Hospital Clínic (Barcelona, Spain), accredited by the
Department of Health and Human Services and regulated
by the Federalwide Assurance for the Protection of Human
Subjects of International (Non-US) Institutions # 00000738
approved the study protocol on 16 July 2002. This trial has
been registered in the London Current Controlled Trialswith the number ISRCTN 35739639 [24]. All participants
provided written informed consent.
Out of 7,447 participants, we excluded 153 participants
with total energy intake out of predefined limits (800 and
4,000 Kcal/day for men and 500 and 3,500 Kcal/day
for women) [25]. Another 1,579 subjects who reported at
baseline prevalent depression, previous history of depression
or use of antidepressant drugs were also excluded (to
ensure the temporal sequence and, therefore, avoid reverse
causation bias). Additionally, 210 participants were lost to
follow-up or did not have alcohol information and
were also excluded. Finally, a subsample of 5,505 par-
ticipants was included in the analyses of the present study
(Additional file 1).Exposure assessment
Alcohol intake was assessed at baseline with a validated
137-item semi-quantitative food-frequency questionnaire
(FFQ), which included nine questions on consumption
of different alcoholic beverages (different types of wine,
beer and spirits). In the validation study for the Spanish
version of this questionnaire, the intra-class correlation
coefficient between alcohol intake from the FFQ and
repeated food records was 0.82 [26]. This FFQ was
repeatedly administered each year during follow-up.
In order to update alcohol information, we considered
alcohol intake using repeated measurements of diet from
all available FFQs. Participants were divided into four
groups according to their alcohol intake: abstainers,
those who reported drinking less than 5 g/day, those with
an intake ranging from >5 to 15 g/day, and the fourth
group with an intake higher than 15 g/day.
To assess the specific role of wine, participants were
divided into five groups according to their average number
of weekly drinks of wine: abstainers, less than one drink/
week, one to less than two drinks/week, two to seven
drinks/week, and more than seven drinks/week. Partici-
pants who did not drink wine but drank other types of
alcoholic beverages were excluded from these specific
analyses.Outcome assessment
An incident case of depression was defined as a diagnosis
of depression made by a physician and reported by partici-
pants in any of the follow-up interviews, or a positive
report of habitual use of antidepressant drugs.Confounder assessment
We obtained information about medical, socio-demo-
graphic, anthropometric and lifestyle variables with
standardized questionnaires (see www.predimed.es) at
the baseline interview.
Gea et al. BMC Medicine 2013, 11:192 Page 3 of 10
http://www.biomedcentral.com/1741-7015/11/192Statistical analysis
Cox regression models were used to assess the relationship
between categories of baseline alcohol intake and the
subsequent incidence of depression during follow-up.
Hazard ratios (HR) and their 95% confidence intervals
(95% CI) were calculated using the abstainers group as
the reference category. Entry time was defined as the
date at recruitment. Exit time was defined as the date at
diagnosis of depression for cases and, for participants who
did not develop depression, as the date when completing
the last interview, 1 December 2010, or date at death,
whichever came first. We adjusted the multivariable models
for the following potential confounders: age, sex, smoking
status (non-smokers, ex-smokers and current smokers),
physical activity (MET-min/d), total energy intake (Kcal/
day), baseline body mass index (kg/m2), marital status
(married or not), intervention group (Mediterranean diet +
virgin olive oil, Mediterranean diet + nuts, low fat diet),
recruiting center (14 centers), educational level (in five
categories from illiterate to university graduate), and
number of persons living at home (living alone or not).
We evaluated the interaction between sex and alcohol
intake on the development of depression by calculating
the likelihood ratio test between the fully adjusted model
and the same model adding the interaction product-term.
To take advantage of the yearly repeated measurements of
diet, we updated the calculation of alcohol intake for
participants every year from baseline to the incidence of
depression from the repeated FFQs. To update alcohol
intake with all available longitudinal data, and to analyze
the association between alcohol intake and depression
at all time-points simultaneously, we used generalized
estimating equations (GEE) with Stata 12.0 (StataCorp,
College Station, TX, USA). We assumed a binomial dis-
tribution with logit models and the unstructured matrix
as the working correlation structure [27]. We defined
the cohort risk as participants who remained free of
depression at the beginning of each two-year follow-up
period. Participants who had been classified as incident
cases were excluded from subsequent follow-up. Then,
only the first incident case of depression was considered
as outcome. In the analysis of repeated measurements,
to allow for a sufficiently long follow-up period, we
modeled the incidence of depression in relation to the
cumulative average alcohol intake from all available
dietary questionnaires up to the start of each two-year
follow-up interval, but we excluded cases occurring in
the first year of that period and took into account only
new cases occurring after one year. For example, for a
participant recruited in 2005 the incidence of depression
from 2007 through 2008 was related to the alcohol intake
reported on the 2005 and 2006 questionnaires. Therefore,
we assumed, an induction period longer than one year
but not longer than two years and alcohol intake wasconsidered as the cumulative average of all available FFQs,
from baseline to the beginning of each two-year follow-up
period. Several sensitivity analyses were conducted refit-
ting Cox regression analyses after a) establishing the 1st
and the 99th or b) the 5th and 95th percentiles of energy
intake as allowable limits, c) after excluding diabetics, d)
after excluding participants older than 75 years, e) after
excluding participants younger than 65 years, f ) after
depurating the abstainers’ group (excluding participants
who reported any alcohol intake throughout their life but
not currently at baseline), g) after including participants
with a prior history of depression at baseline and including
this variable in the multiple adjusted model, and h) after
establishing a two- to three-year induction period (instead
of one to two years) between exposure and outcome in
the repeated measurement analyses. Moreover, to assess
the influence of wine consumption on the development of
depression, we conducted both Cox regression and GEE
analyses, using abstainers as the reference category. In these
analyses, we adjusted for the same potential confounders as
mentioned above, and also for alcohol intake from other
sources. Additionally, we re-ran the analyses for wine
consumption among only-wine drinkers to control for
confounding by other alcoholic beverages.
Moreover, we evaluated the potential non-linear associ-
ation between alcohol intake and incident depression with
the use of restricted cubic splines, for participants drinking
no more than 80 grams of alcohol per day (99.42% of
participants) [28].
Finally, we examined the incidence and recovery from
depression applying fixed-effects regression as suggested
by Fergusson et al. [29] to control for observed and non-
observed factors that do not vary for a subject over time.
Results
The main characteristics of the 5,505 participants (2,683
males and 2,822 females) according to their total alcohol
intake are shown in Table 1. As mentioned before, this
Mediterranean population consisted of older men and wo-
men, with a mean age of 67 years. Higher alcohol intake
was positively associated with being male (88% of partici-
pants drinking more than 15 g/day were male), practicing
more leisure-time physical activity, being a current or for-
mer smoker, having higher total energy intake, being mar-
ried, but it was inversely associated with educational level.
A total of 443 incident cases of depression were identi-
fied during the follow-up period, which accrued 23,655
person-years.
The Cox regression analysis using baseline alcohol intake
as exposure showed an inverse association between total
alcohol intake and the incidence of depression, with no sig-
nificant linear or quadratic trend in the multiple-adjusted
analyses. In the multiple-adjusted model, only the associ-
ation for the category of low-to-moderate intake (>5 to 15
Table 1 Baseline characteristics of participants according to baseline alcohol intake
Alcohol intake categories (g/day)
0 >0 to 5 >5 to 15 >15
N 1,818 1,356 1,279 1,052
Sex (female %) 78 59 38 12
Age (years) 68.5 (6.1) 67.0 (6.1) 66.4 (6.2) 65.6 (6.1)
BMI (kg/m2) 30.3 (4.1) 30.0 (3.9) 29.4 (3.5) 29.3 (3.3)
Leisure time physical activity (MET-min/d) 201 (210) 230 (232) 267 (276) 318 (270)
Secondary school or higher (%) 13 23 28 36
Current smokers (%) 7 12 17 29
Former smokers (%) 15 24 36 44
Marital status (% married) 71 78 84 89
Living alone (%) 12 9 7 5
Total energy intake (Kcal/day) 2,054 (511) 2,184 (509) 2,330 (511) 2,595 (533)
Alcohol (g/day) - 2.0 (1.4) 9.8 (2.7) 35 (17)
Wine (g alcohol/day) - 1.3 (1.4) 7.4 (3.7) 25 (16)
Beer (g alcohol/day) - 0.5 (0.9) 1.7 (2.7) 4.8 (8.4)
Spirits (g alcohol/day) - 0.2 (0.5) 0.6 (1.5) 4.2 (8.8)
Mean and Standard Deviations, or %. The PREDIMED Study 2003 to 2010. BMI, body mass index; MET, metabolic equivalent task.
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0.72 (0.53 to 0.98)) (Table 2). Examining the association for
those participants who drank more than 40 g/day, we
found that they were at higher risk but this association was
not statistically significant, probably due to the small num-
ber of heavy drinkers (HR (95% CI = 1.34 (0.69 to 2.59)).
In the repeated-measurement analyses using as exposure
the yearly updated information on alcohol intake, we
observed a stronger inverse association. We found a
statistically significant inverse association for light drinkers
(>0 to 5 g/day) with a relative risk (95% CI) of 0.73 (0.57 to
0.95) and also for low-to-moderate drinkers (>5 to 15Table 2 Risks of depression according to categories of daily a
Alcohol intake categories (g/day) 0 >0 to 5
Baseline alcohol intakea
Cases/Person-years 195/7,777 114/5,728
Crude model 1 (Ref.) 0.79 (0.63 to 1.00)
Age and sex-adjusted 1 (Ref.) 0.91 (0.72 to 1.15)
Multiple-adjusted modelc 1 (Ref.) 0.97 (0.75 to 1.25)
Updated alcohol intakeb
Crude model 1 (Ref.) 0.63 (0.49 to 0.81)
Age and sex-adjusted 1 (Ref.) 0.73 (0.56 to 0.94)
Multiple-adjusted modelc 1 (Ref.) 0.73 (0.57 to 0.95)
aHazard ratios (95% confidence intervals) for incident depression according to categ
bRelative risks (95% confidence intervals) for categories of updated alcohol intake, u
causality bias, an induction period of at least one year, but no longer than two year
only during the second year of every two-year follow-up interval.
cAdjusted for age, sex, smoking, physical activity (MET-min/d), total energy intake (K
recruiting center, educational level and the number of persons living at home.
The PREDIMED Study 2003 to 2010.g/day) with a relative risk of 0.69 (0.50 to 0.96). We
found no effect modification of alcohol intake by sex
(P = 0.45). Although the interaction was non-significant,
we re-ran the analyses separately for men and women to
take into account biological differences between the sexes.
The results are available in the supplementary material
(Additional file 2).
To account for a non-linear association, we used re-
stricted cubic spline analysis. The U-shaped association
found, represented in Figure 1, showed a consistent pro-
tection against incident depression for baseline moderate
alcohol intake.lcohol intake
>5 to 15 >15 P for liner trend
79/5,390 55/4,760
0.59 (0.46 to 0.77) 0.44 (0.33 to 0.60) <0.001
0.81 (0.62 to 1.07) 0.81 (0.58 to 1.14) 0.347
0.72 (0.53 to 0.98) 0.79 (0.53 to 1.16) 0.522
0.49 (0.37 to 0.66) 0.37 (0.26 to 0.52) <0.001
0.71 (0.52 to 0.97) 0.71 (0.48 to 1.05) 0.727
0.69 (0.50 to 0.96) 0.69 (0.46 to 1.04) 0.773
ories of baseline daily alcohol intake.
sing repeated measurements of diet during follow-up. To avoid reverse
s was assumed. We considered as incident cases of depression those occurring
cal/day), baseline body mass index (kg/m2), marital status, intervention group,
Figure 1 Dose–response relationship between alcohol intake
(g/day) and depression risk (HR and 95% CI). Restricted cubic
spline model. The PREDIMED Study 2003 to 2010. The black line
represents the HR and the dashed lines represent the 95%
confidence interval. Adjusted for age, smoking, physical activity
(MET-min/d), total energy intake (Kcal/day), baseline body mass
index (kg/m2), marital status, intervention group, recruiting center,
educational level and the number of persons living at home.
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associated with the incidence of depression (Table 3). In
the multiple-adjusted model, we found a HR (95% CI) of
0.68 (0.47 to 0.98) for the baseline consumption of two to
seven drinks/week of wine. Using repeated measurements
to update wine consumption, we also observed a strength-
ening of this inverse association with a relative risk of 0.57
(0.40 to 0.79) for those who drank two to seven drinks/
week of wine. In our sample, 1,350 participants were only-
wine drinkers. Among them the results were consistent
with those previously discussed (Table 3). Wine consump-
tion accounted for 82% of alcohol intake variability in this
sample. The number of only-beer drinkers was just 308
and the number of only-spirits drinkers was 61. Only
1.63% of participants drank more than one drink/day of
beer, and only 0.09% of spirits. Consequently, we could
not do for beer or spirits the type of separate analysis that
we did for wine. In order to investigate possible sources of
bias in the estimation of the relationship between alcohol
intake and depression, we conducted several sensitivity
analyses (Table 4). Results did not substantially change
except when excluding diabetics and for other analyses
with a substantial number of exclusions, probably due to a
lack of statistical power.
Results were also consistent when we investigated the
incidence and recovery from depression using fixed-effects
models (Additional file 3).Discussion
We found that total low-to-moderate alcohol drinking
(5 to 15 g/day) was associated with lower risk of depression.A stronger inverse association was found for low-to-moder-
ate wine-drinkers (two to seven glasses/week).
These results seem paradoxical as previous studies found
a direct association between alcohol in higher amounts,
especially Alcohol Use Disorders (AUD), and depressive
symptoms, [11,17-20,30]. However, lower amounts of alco-
hol intake might exert a protection as it has been observed
for coronary heart disease (CHD). In fact, it is believed that
depression and CHD share common pathophysiological
mechanisms [30,31]. Only one previous cohort, including
participants with a high educational level, assessed low-
to-moderate levels of intake and found a similar inverse
association (HR (95% CI); 0.65 (0.49 to 0.86)) for the
same range of exposure 5 to 15 g/day that we have ob-
served [9]. The results of our study and that previous
cohort are, therefore, closely consistent. The practical
absence of heavy drinkers in our sample and in that co-
hort, together with the large proportion of participants
exposed to low-to-moderate intakes are likely explana-
tions for the diverging results with respect to cohorts
including heavy drinkers. The results of those studies
have to be carefully interpreted. In several previous
cross-sectional studies, a strong positive association was
found. Therefore, the definition of a clear temporal se-
quence is necessary to preclude the possibility of a reverse
causation bias [3]. Some longitudinal studies have assessed
the reverse direction of this association, that is, the conse-
quences of depression on alcohol intake. They have found
direct associations; subjects with depression tend to in-
crease their alcohol intake as a consequence of their mood
disorder [2]. Therefore, in some cross-sectional analyses,
the positive association found is likely to be the result of
the direct effect of depression on alcohol intake, which may
overcome the possible inverse association between low-to
-moderate alcohol intake and depression risk. They can
also capture the detrimental effects of higher amounts of
alcohol intake on depression risk. In contrast, in a longitu-
dinal analysis, the temporal sequence is preserved, and re-
verse causation bias is less likely. In order to minimize
the risk of that bias, we assumed an induction period of at
least one year and we conducted a sensitivity analysis as-
suming an alternative induction period of two to three
years in the repeated measurement analyses. Early cases
may be subclinical cases of depression at the beginning of
the interval and may correspond to subjects who changed
their alcohol intake before developing overt clinical depres-
sion. The fact that the results of these sensitivity analyses
are consistent with the main results gives further support
to our findings. Moreover, incident cases of depression did
not change their alcohol intake differently from those who
were not incident cases (P >0.1; data not shown).
The differences between our results and those of previous
studies could also be explained by the different average
alcohol intake between populations, the different pattern
Table 3 Risks of depression according to weekly wine consumption
Wine: drinks/week Abstainers <1 1 to <2 2 to 7 >7
Baseline wine consumptiona
Cases/Person-years 195/7,777 44/2,461 28/1,708 57/3,183 32/6,828
Age and sex-adjusted model 1 (Ref.) 1.05 (0.78 to 1.42) 0.82 (0.55 to 1.22) 0.75 (0.54 to 1.05) 0.79 (0.60 to 1.04)
Multiple-adjusted modelc 1 (Ref.) 1.00 (0.72 to 1.39) 0.93 (0.61 to 1.43) 0.70 (0.48 to 1.00) 0.78 (0.57 to 1.06)
Multiple-adjusted modeld 1 (Ref.) 0.99 (0.71 to 1.37) 0.92 (0.60 to 1.41) 0.68 (0.47 to 0.98) 0.76 (0.56 to 1.04)
Updated wine consumptionb
Age-adjusted model 1 (Ref.) 0.64 (0.46 to 0.89) 0.86 (0.58 to 1.27) 0.59 (0.43 to 0.82) 0.70 (0.48 to 1.02)
Multiple-adjusted modelc 1 (Ref.) 0.64 (0.46 to 0.89) 0.87 (0.58 to 1.29) 0.57 (0.41 to 0.80) 0.68 (0.46 to 1.01)
Multiple-adjusted modeld 1 (Ref.) 0.63 (0.46 to 0.89) 0.86 (0.58 to 1.28) 0.57 (0.40 to 0.79) 0.66 (0.45 to 0.99)
Baseline wine consumption (Only wine-drinkers)a
Cases/Person-years 195/7,777 40/1,454 13/752 25/1,363 26/2,236
Age-adjusted model 1 (Ref.) 1.13 (0.80 to 1.59) 0.79 (0.45 to 1.38) 0.86 (0.56 to 1.30) 0.59 (0.39 to 0.90)
Multiple-adjusted modelc 1 (Ref.) 1.18 (0.81 to 1.72) 0.91 (0.49 to 1.69) 0.81 (0.50 to 1.30) 0.55 (0.35 to 0.87)
Updated wine consumption (Only wine-drinkers)b
Age-adjusted model 1 (Ref.) 0.54 (0.34 to 0.87) 0.93 (0.52 to 1.66) 0.58 (0.36 to 0.92) 0.52 (0.24 to 1.14)
Multiple-adjusted modelc 1 (Ref.) 0.55 (0.34 to 0.87) 0.93 (0.52 to 1.66) 0.57 (0.36 to 0.92) 0.52 (0.23 to 1.18)
aHazard ratios (95% confidence intervals) for incident depression according to categories of baseline daily alcohol intake.
bRelative risks (95% confidence intervals) for categories of updated alcohol intake, using repeated measurements of diet during follow-up. To avoid reverse
causality bias, an induction period of at least one year, but no longer than two years was assumed. We considered as incident cases of depression those occurring
only during the second year of every two-year follow-up interval.
cAdjusted for age, smoking, physical activity (MET-min/d), total energy intake (Kcal/day), baseline body mass index (kg/m2), marital status, intervention group,
recruiting center, educational level and the number of persons living at home.
dAdding alcohol from sources other than wine to the previous multiple-adjusted model.
The PREDIMED Study 2003 to 2010.
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type of beverage consumed is different, wine being the
preferential beverage in our cohort. The PREDIMED
trial includes an older, traditional Spanish Mediterranean
population, that consumed chiefly wine, and mainly in a
context of socialization with family or friends. Subjects
with problematic use of alcohol (≥2 positive answers inTable 4 Sensitivity analyses
Overall
Energy limits: percentiles 5 to 95
Energy limits: percentiles 1 to 99
Excluding diabetics
Excluding participants older than 75
Excluding participants younger than 65
Depurating abstainers’ groupa
Including participants with prior depression at baseline
Updated alcohol intake assuming induction period: 1 to 2 yearsb
Updated alcohol intake assuming induction period: 2 to 3 yearsb
aAfter excluding those participants who reported any alcohol intake throughout the
bRepeated-measurement analysis. Relative risks (95% confidence interval) for incide
Considering incident cases during the last year of every two-year follow-up interval
The PREDIMED Study 2003 to 2010.
All adjusted for age, sex, smoking, physical activity (MET-min/d), total energy intake
group, recruiting center, educational level, the number of persons living at home anthe CAGE questionnaire) [21] were explicitly excluded
from this trial because this was one of the exclusion criteria.
Moreover, they were in a trial where an intervention with
a Mediterranean diet was done, including the advice to
consume wine moderately only for those who were
already wine drinkers at inception. However, the interven-
tion designed for this trial did not attain any significantTotal cases/person-years >5 to 5 g/day
443/23,655 0.72 (0.53 to 0.98)
403/21,681 0.78 (0.57 to 1.06)
444/23,675 0.71 (0.53 to 0.96)
227/11,653 0.96 (0.64 to 1.44)
389/21,200 0.73 (0.56 to 1.25)
307/14,785 0.75 (0.52 to 1.06)
422/22,882 0.75 (0.55 to 1.02)
817/25,868 0.72 (0.57 to 0.90)
- 0.69 (0.50 to 0.96)
- 0.68 (0.47 to 1.00)
ir life but not currently at baseline.
nt depression according to yearly updated measurements of alcohol intake.
.
(Kcal/day), baseline body mass index (kg/m2), marital status, intervention
d alcohol intake at baseline.
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g/day, and −0.9 g/day in the Mediterranean diet + virgin
olive oil, Mediterranean diet + nuts and control groups, re-
spectively) without any between-group significant differ-
ence. In addition, the Mediterranean diet has also been
associated with lower incidence of depression [32]. There-
fore, dummy variables for the two active intervention
groups were included in the multiple-adjusted model as
potential confounders.
The relationship between alcohol intake and depression
is biologically different among men and women [20,33,34].
For instance, alcohol bioavailability is different between
sexes [35], and women seem to be more likely to develop
depression [36]. Therefore, we presented the analyses strati-
fied by sex despite there being no evidence of statistical
interaction by sex.
Besides the sensitivity analysis mentioned above, we
conducted eight other sensitivity analyses to explore
further potential sources of bias. The reference category
in the main analysis was the abstainers’ group. This group
may include former drinkers. Therefore, we excluded from
the abstainers’ group all participants who reported drinking
alcohol ever in her/his past life, and the results remained
similar. However, the results became non-significant after
the exclusion of prevalent diabetics at baseline. This fact
may be explained by a loss of statistical power because
almost 50% of our participants were diabetics. Alternatively,
it might be attributed to a better disease classification
among diabetic than among non-diabetic participants.
Diabetics usually are more likely to have more frequent
medical visits due to their diabetes; therefore, they have
more opportunities to receive a medical diagnosis of
depression than non-diabetic patients.
To our knowledge, with the exception of the recent
results of the University of Navarra follow-up Study
(“Seguimiento Universidad de Navarra” (SUN cohort)),
no other large prospective cohort study has previously
reported conclusive results about the relationship between
specific alcoholic beverages and incident depression.
Non-alcoholic components of wine can account for the
inverse association found in our study. For instance,
trans-resveratrol has been postulated as a neuroprotective
substance [37-40]. Previous investigations suggest that the
hippocampal complex may play a role in the development
of major depression [41]. This neuroprotection applied to
the hippocampus may prevent moderate wine drinkers
from developing depression.
An alternative potential explanation for this association
can be that wine-drinkers or moderate drinkers might be
healthier in other aspects than non-wine drinkers or
non-moderate drinkers, as it has been suggested for other
outcomes [42]. In order to account for confounding by
these factors, several lifestyle variables, including quality
of the diet and several indicators of an overall healthylifestyle and health consciousness, had been included in
the multiple-adjusted model.
Some important strengths of the present study are its
prospective design, the use of repeated measurements of
alcohol intake during follow-up, the large sample size of
a very homogeneous population and the good adjustment
for potential confounders. In addition, the high prevalence
of low-to-moderate average alcohol intake with almost
null prevalence of excessive drinking together with the
preference for wine consumption offered a unique oppor-
tunity to investigate the influence of these two particular
factors (light-to-moderate drinking and wine consumption),
while it limited our power to detect associations between
heavy drinking and depression.
Inherent to nutritional epidemiology methods, we have
to point out the possibility of some degree of misclassifi-
cation in the dietary assessment methods. However, we
used a FFQ extensively validated in Spain for the dietary
assessment [26,43,44]. In addition, the correlation coeffi-
cient in the validation study was higher for alcohol than
for most other nutrients. Moreover, if there is some mis-
classification it will be more likely non-differential and,
therefore, the association would probably be driven
towards the null value. Another limitation in our study is
that we are not exclusively using a clinical diagnosis of
depression. Probably we are achieving a high specificity at
the expense of losing sensitivity. Moreover, there is a
possibility that patterns of alcohol consumption may be
associated with decisions to seek care. If heavy drinkers
were less likely to seek medical care, this could result in
the rates of depression being under-estimated among
heavy drinkers.
Conclusions
In conclusion, low-to-moderate total alcohol intake and
specifically wine consumption may reduce incident de-
pression, while heavy drinkers seem to be at higher risk.
Further cohort studies are needed to confirm these
results.Additional files
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